Literature DB >> 20874852

Intra- and inter-laboratory variability in human T-cell leukemia virus type-1 proviral load quantification using real-time polymerase chain reaction assays: a multi-center study.

Shimeru Kamihira1, Yoshihisa Yamano, Masako Iwanaga, Daisuke Sasaki, Masahiro Satake, Akihiko Okayama, Kazumi Umeki, Ryuji Kubota, Shuji Izumo, Kazunari Yamaguchi, Toshiki Watanabe.   

Abstract

Human T-cell leukemia virus type-1 (HTLV-1) proviral load (VL) is an important determinant of viral pathogenesis and malignant evolution. Although VL has been quantified by in-house real-time quantifiable polymerase chain reaction (qPCR) technology, little is known about the harmonization among different VL assay systems. We evaluated intra- and inter-laboratory variability of VL measured at six laboratories using the same DNA samples seropositive for HTLV-1 in a two-step manner. The first study measured 60 samples by original in-house assays, finding that the median intra- and inter-laboratory coefficient of variation (CV) was 44.9% (range, 25.4-71.8%) and 59.9% (34.2-93.4%), respectively. The inter-laboratory correlation coefficients ranged from 0.760 to 0.875, indicating that VL were measured with good precision in each laboratory, but inter-laboratory regression slopes differed from 0.399 to 2.206, indicating that VL were measured with a wide variation between laboratories. To examine the effect of standardization of reference materials (RM) on the VL variability, we performed a second study using only 20 samples by substituting RM for plasmid including the HTLV-1 pX region. The median inter-laboratory CV for raw pX copy number was reduced significantly from 66.9% to 35.7%, whereas the median CV for the internal control remained almost unchanged, resulting in no improvement in inter-laboratory CV for VL. This indicates that each in-house assay system worked well with good precision, but standardizing RM alone was insufficient for harmonization. The relevant choice of not only RM, but also internal control genes for data normalization is expected to be realistic to standardize HTLV-1 VL measurement.
© 2010 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20874852     DOI: 10.1111/j.1349-7006.2010.01720.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  9 in total

1.  Standardization of Quantitative PCR for Human T-Cell Leukemia Virus Type 1 in Japan: a Collaborative Study.

Authors:  Madoka Kuramitsu; Kazu Okuma; Tadanori Yamochi; Tomoo Sato; Daisuke Sasaki; Hiroo Hasegawa; Kazumi Umeki; Ryuji Kubota; Rieko Sobata; Chieko Matsumoto; Noriaki Kaneko; Isao Naruse; Makoto Yamagishi; Makoto Nakashima; Haruka Momose; Kumiko Araki; Takuo Mizukami; Saeko Mizusawa; Yoshiaki Okada; Masaki Ochiai; Atae Utsunomiya; Ki-Ryang Koh; Masao Ogata; Kisato Nosaka; Kaoru Uchimaru; Masako Iwanaga; Yasuko Sagara; Yoshihisa Yamano; Masahiro Satake; Akihiko Okayama; Manabu Mochizuki; Shuji Izumo; Shigeru Saito; Kazuo Itabashi; Shimeru Kamihira; Kazunari Yamaguchi; Toshiki Watanabe; Isao Hamaguchi
Journal:  J Clin Microbiol       Date:  2015-08-19       Impact factor: 5.948

2.  HTLV-1 targets human placental trophoblasts in seropositive pregnant women.

Authors:  Kenta Tezuka; Naoki Fuchi; Kazu Okuma; Takashi Tsukiyama; Shoko Miura; Yuri Hasegawa; Ai Nagata; Nahoko Komatsu; Hiroo Hasegawa; Daisuke Sasaki; Eita Sasaki; Takuo Mizukami; Madoka Kuramitsu; Sahoko Matsuoka; Katsunori Yanagihara; Kiyonori Miura; Isao Hamaguchi
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

3.  Identification of TL-Om1, an adult T-cell leukemia (ATL) cell line, as reference material for quantitative PCR for human T-lymphotropic virus 1.

Authors:  Madoka Kuramitsu; Kazu Okuma; Makoto Yamagishi; Tadanori Yamochi; Sanaz Firouzi; Haruka Momose; Takuo Mizukami; Kazuya Takizawa; Kumiko Araki; Kazuo Sugamura; Kazunari Yamaguchi; Toshiki Watanabe; Isao Hamaguchi
Journal:  J Clin Microbiol       Date:  2014-12-10       Impact factor: 5.948

4.  HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells.

Authors:  Natsumi Araya; Tomoo Sato; Hitoshi Ando; Utano Tomaru; Mari Yoshida; Ariella Coler-Reilly; Naoko Yagishita; Junji Yamauchi; Atsuhiko Hasegawa; Mari Kannagi; Yasuhiro Hasegawa; Katsunori Takahashi; Yasuo Kunitomo; Yuetsu Tanaka; Toshihiro Nakajima; Kusuki Nishioka; Atae Utsunomiya; Steven Jacobson; Yoshihisa Yamano
Journal:  J Clin Invest       Date:  2014-06-24       Impact factor: 14.808

5.  Tumor necrosis factor alpha inhibitors have no effect on a human T-lymphotropic virus type-I (HTLV-I)-infected cell line from patients with HTLV-I-associated myelopathy.

Authors:  Shoichi Fukui; Hideki Nakamura; Yoshiko Takahashi; Naoki Iwamoto; Hiroo Hasegawa; Katsunori Yanagihara; Tatsufumi Nakamura; Akihiko Okayama; Atsushi Kawakami
Journal:  BMC Immunol       Date:  2017-02-03       Impact factor: 3.615

6.  Tocilizumab has no direct effect on cell lines infected with human T-cell leukemia virus type 1.

Authors:  Yushiro Endo; Shoichi Fukui; Tomohiro Koga; Daisuke Sasaki; Hiroo Hasegawa; Katsunori Yanagihara; Akihiko Okayama; Tatsufumi Nakamura; Atsushi Kawakami; Hideki Nakamura
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

7.  Brazilian Protocol for Sexually Transmitted Infections 2020: human T-cell lymphotropic virus (HTLV) infection.

Authors:  Carolina Rosadas; Carlos Brites; Denise Arakaki-Sanchez; Jorge Casseb; Ricardo Ishak
Journal:  Rev Soc Bras Med Trop       Date:  2021-05-17       Impact factor: 1.581

8.  Development and Validation of Multiplex Quantitative Real-Time PCR Assays for Simultaneous Detection and Differentiation of HTLV-1 and HTLV-2, Using Different PCR Platforms and Reagent Brands.

Authors:  Maria Gisele Gonçalves; Lucila Okuyama Fukasawa; Karoline Rodrigues Campos; Fábio Takenori Higa; Adele Caterino-de-Araujo
Journal:  Front Microbiol       Date:  2022-03-15       Impact factor: 5.640

9.  Establishment of a novel diagnostic test algorithm for human T-cell leukemia virus type 1 infection with line immunoassay replacement of western blotting: a collaborative study for performance evaluation of diagnostic assays in Japan.

Authors:  Kazu Okuma; Madoka Kuramitsu; Toshihiro Niwa; Tomokuni Taniguchi; Yumiko Masaki; Gohzoh Ueda; Chieko Matsumoto; Rieko Sobata; Yasuko Sagara; Hitomi Nakamura; Masahiro Satake; Kiyonori Miura; Naoki Fuchi; Hideaki Masuzaki; Akihiko Okayama; Kazumi Umeki; Yoshihisa Yamano; Tomoo Sato; Masako Iwanaga; Kaoru Uchimaru; Makoto Nakashima; Atae Utsunomiya; Ryuji Kubota; Kenji Ishitsuka; Hiroo Hasegawa; Daisuke Sasaki; Ki-Ryang Koh; Mai Taki; Kisato Nosaka; Masao Ogata; Isao Naruse; Noriaki Kaneko; Sara Okajima; Kenta Tezuka; Emi Ikebe; Sahoko Matsuoka; Kazuo Itabashi; Shigeru Saito; Toshiki Watanabe; Isao Hamaguchi
Journal:  Retrovirology       Date:  2020-08-24       Impact factor: 4.602

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.